00:00More bids are in higher price. The war continues. Does it feel like one of the either between Pfizer and Novo is really in the lead to take this company. Well according to Met Sarah Novo's increased offer is still better than Pfizer's. But in about an hour we're actually going to see this continue to play out in court in Delaware because Pfizer is trying to get from last week Novo's increased bid there. It sort of started a countdown or a clock of four days for Pfizer to increase
00:29its offer. So Pfizer sued last week to sort of stop that process from happening. That hearing is still happening according to our sources at least in about an hour as at the same time these companies are now increasing their bid. So the drama is continuing to play out that Sarah is saying that again Novo's offer is better but remains to be seen sort of what happens in the court. So Novo sells. Obviously we go VNO Zempic. Eli Lilly has the terms of times.
00:59Zet bound and Monjaro which is a horrible name for something that makes you stop eating. What does Met Sarah have for Pfizer. Is it is it also a GLP one. Yeah. So Met Sarah has a couple of different drugs in development. One of them is a longer acting GLP one. So it's similar to a govino Zempic but you only have to inject it inject it once a month versus every week like the drugs that are currently on the market.
01:23And then they also have what's called an amylin drug. And so that's a little bit different. It's a different hormone. It's not GLP one. It's thought to have fewer side effects but work you know just as effectively for weight loss.
01:36So Pfizer is looking at this and saying we're not in obesity yet. And so this company has drugs that are potentially better than what's on the market today.
01:44And so if we're going to you know sort of play the long game here and have to be in this next wave of companies that are getting into the obesity space. Why not buy a company that has potentially better drugs and sort of this next generation wave of treatments.
Comments